Biotech executive facing end-stage cancer and the seduction of experimental drugs

Michael Becker and his dog. Image credit: Michael Becker

For years, Michael Becker was one of the drug executives navigating swarms of cancer doctors at the annual meeting of American Society of Clinical Oncology.

This year he came back, but it was very different. This time he spoke to an audience of drug executives as a patient living on borrowed time. Becker has been on a personal crusade to raise awareness about the human papillomavirus, or HPV, which caused the cancer that will likely kill him–possibly soon.

He finagled his way into a clinical trial of an experimental drug, but the side effects were excruciating as one of his lungs filled with fluid and required a tube to drain it. After that, he had to be convinced to try chemotherapy, which, in fact, did make his tumors, which had spread to his lungs, shrink. He’s living proof, he says, that even an expert can be seduced by the promise of an experimental drug, even when there is a better alternative.

Related article:  Was the EPA right not to ban the crop pesticide chlorpyrifos?

Chemotherapy shrank his tumors at first, but eventually it stopped and Becker decided he couldn’t take its mounting side effects.

He knows that his next scans may show his tumors growing again but says he still doesn’t think he wants to try another treatment.

We’d like to thank Mike for letting us, and now you, into his life.

Read full, original post: A Biotech Executive Faces End-Stage Cancer As A Patient

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
ft covidresponseus feature

Video: Viewpoint: The US wrote the global playbook on the coronavirus and then ignored it

A year ago, the United States was regarded as the country best prepared for a pandemic. Our government had spent ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
gmo corn field x

Do GMO Bt (insect-resistant) crops pose a threat to human health or the environment?

Bt is a bacterium found organically in the soil. It is extremely effective in repelling or killing target insects but ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend